Last Posted: Dec 12, 2019
- Implementing universal cancer screening programs can help sustain genomic medicine programs.
Rahm Alanna Kulchak et al. Personalized medicine 2019 Dec - Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico.
Dutil Julie et al. Scientific reports 2019 Nov 9(1) 17769 - Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
et al. Obstetrics and gynecology 2019 Dec 134(6) e143-e149 - Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
et al. Obstetrics and gynecology 2019 Dec 134(6) 1366-1367 - Hereditary cancer syndromes: Are your patients at risk?
Self paced course from the Jackson Laboratory - Communication and Decision Making for Individuals with Inherited Cancer Syndromes
NCI, November 2019 - Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.
Underhill Meghan L et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2019 Nov - Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Elsayegh Nisreen et al. Cancer medicine 2018 7(6) 2718-2726 - Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
Vysotskaia Valentina et al. Cancer 2019 Nov - Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program.
Dwarte Tanya et al. Hereditary cancer in clinical practice 2019 1730
.png)
No hay comentarios:
Publicar un comentario